HIV, tobacco use, and poverty: A potential cause of disparities in health status by race and socioeconomic status

Journal of Health Care for the Poor and Underserved

Volumn 24, Issue 3, 2013, Pages 1215-1225

  Anang Sowah, Leonard ^a   Busse, Sarah ^a   Amoroso, Anthony ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Disparities in heath; Ethnicity; HIV (human immunodeficiency virus); Poverty; Smoking

Indexed keywords

ADULT; ANCESTRY GROUP; FEMALE; HEALTH DISPARITY; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NOTE; POVERTY; SMOKING; UNITED STATES;

ADULT; CONTINENTAL POPULATION GROUPS; FEMALE; HEALTH PROMOTION; HEALTH STATUS DISPARITIES; HIV SEROPOSITIVITY; HUMANS; MALE; POVERTY; SMOKING; UNITED STATES;

EID: 84883175071     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2013.0136     Document Type: Note

References (67)

1. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas: 2010. Atlanta, Georgia: Centers for Disease Control and Prevention/HIV Surveillance Report, Volume 22, 2012.
2. Riley ED, Gandhi M, Bradley Hare C, et al. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS Rep. 2007 Dec; 4(4): 181-6.
3. Zierler S, Krieger N, Tang Y, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000 Jul; 90(7): 1064-73.
4. Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006 Jul; 33(7 Suppl):S39-45.
5. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001 Jul; 91(7): 1060-8.
6. Gillespie S, Kadiyala S, Greener R, et al. Is poverty or wealth driving HIV transmission? AIDS. 2007 Nov; 21(Suppl 7): S5-16.
7. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008 Nov; 57(45): 1226-8.
8. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 100(23): 1672-94.
9. Jemal A, Ward E, Thun M, et al. Declining death rates reflct progress against cancer. PLoS One. 2010 Mar; 5(3):e9584.
10. Pleis JR, Ward BW, Lucas JW. Summary health statistics for US adults: National Health Interview Survey, 2009. Vital Health Stat 10. 2010 Dec;(249): 1-207.
11. Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged ≥18 Years-United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2011 Sep; 60(35): 1207-12.
12. Giovino GA. Epidemiology of tobacco use in the United States. Oncogene. 2002 Oct; 21(48): 7326-40.
13. Williams DR, Jackson PB. Social sources of racial disparities in health. Health Aff (Millwood). 2005 Mar-Apr; 24(2): 325-34.
14. Schroeder SA. Shattuck lecture. We can do better-improving the health of the American people. N Engl J Med. 2007 Sep; 357(12): 1221-8.
15. Moolchan ET, Fagan P, Fernander AF, et al. Addressing tobacco related health disparities. Addiction. 2007 Oct; 102(Suppl 2): 30-42.
16. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003 Sep; 362(9387): 847-52.
17. de Beyer J, Lovelace C, Yurekli A. et al. Poverty and tobacco. "Tob Control. 2001 Sep; 10(3): 210-11.
18. Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged ≥18 years-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010 Sep; 59(35): 1135-40.
19. Barbeau EM, Krieger N, Soobader MJ. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004 Feb; 94(2): 269-78.
20. Schaap MM, Kunst AE. Monitoring of socioeconomic inequalities in smoking: learning from the experiences of recent scientifitudies. Public Health. 2009 Feb; 123(2): 103-9.
21. Siahpush M, Yong HH, Borland R, et al. Smokers with fiancial stress are more likely to want to quit but less likely to try or succeed: fidings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2009 Aug; 104(8): 1382-90.
22. Gandhi KK, Foulds J, Steinberg MB, et al. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009 Mar; 63(3): 360-7.
23. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, et al. HIV-positive smokers considering quitting: differences by race/ethnicity. Am J Health Behav. 2008 Jan-Feb; 32(1): 3-15.
24. Darmon N, Drewnowski A. Does social class predict diet quality? Am J Clin Nutr. 2008 May; 87(5): 1107-17.
25. Lien N, Jacobs DR Jr, Klepp KI. Exploring predictors of eating behaviour among adolescents by gender and socioeconomic status. Public Health Nutr. 2002 Oct; 5(5): 671-81.
26. Healton C, Nelson K. Reversal of misfortune: viewing tobacco as a social justice issue. Am J Public Health. 2004 Feb; 94(2): 186-91.
27. Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010 Apr; 100(4): 590-5.
28. Kelly A. Quitting tobacco: save lives, save money in Medicaid and state employee plans. Lexington, KY: Council of State Governments, 2010 Oct. Available at: http:// knowledgecenter.csg.org/drupal/system/fies/CR_Tobacco_Cessation.pdf.
29. U.S. Congress. Patient Protection and Affrdable Care Act of 2010: Public Law. 2010: 111-48. Washington, DC: U.S. Congress, 2010.
30. American Lung Association. Helping smokers quit: state tobacco cessation. Washington, DC: American Lung Association, 2011 Dec. Available at: http://www.lung.org /assets/documents/publications/smoking-cessation/helping-smokers-quit-2011.pdf.
31. Tobacco Use and Dependence Guideline Panel. Treating tobacco use and dependence: 2008 Update: Rockville, MD: U.S. Department of Health and Human Services, 2008 May.
32. Rigotti NA. Clinical practice: treatment of tobacco use and dependence. N Engl J Med. 2002 Feb; 346(7): 506-12.
33. Walter U, Flick U, Neuber A, et al. Putting prevention into practice: qualitative study of factors that inhibit and promote preventive care by general practitioners, with a focus on elderly patients. BMC Fam Pract. 2010 Sep; 11: 68.
34. Bitton A, Green C, Colbert J. Improving the delivery of global tobacco control. Mt Sinai J Med. 2011 May-Jun; 78(3): 382-93.
35. Lewis S, Russell A. Young smokers' narratives: public health, disadvantage and structural violence. Sociol Health Illn. 2012 Nov 12; Epub ahead of print.
36. Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004 Feb; 6(1): 71-7.
37. Tesoriero JM, Gieryic SM, Carrascal A, et al. Smoking among HIV-positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010 Aug; 14(4): 824-35.
38. Cliffrd GM, Polesel J, Rickenbach M, et al.; Cancer risk in the Swiss HIV Cohort Study: associations with immunodefiiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005 Mar; 97(6): 425-32.
39. Currier JS. Update on cardiovascular complications in HIV infection. Top HIV Med. 2009 Jul-Aug; 17(3): 98-103.
40. Calvo-Sánchez M, Perelló R, Perez I, et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Med. 2013 Jan; 14(1): 40-8.
41. Kirk GD, Merlo C, O'Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007 Jul; 45(1): 103-10.
42. Centers for Disease Control and Prevention. 1993 revised classifiation system for HIV infection and expanded surveillance case defiition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992 Dec; 41(RR-17): 1-19.
43. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst. 1999 Mar; 91(6): 506-11.
44. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 Apr; 55(4): 244-65.
45. Kjaer SK, Munk C, Falck Winther J, et al. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6): 1528-33.
46. Vaccarella S, Herrero R, Snijders PJ, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol. 2008 Jun; 37(3): 536-46.
47. Sarian LO, Derchain SF, Pitta Dda R, et al. Factors associated with HPV persistence aft er treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol. 2004 Dec; 31(4): 270-4.
48. Wiley DJ, Elashoff D, Masongsong EV, et al. Smoking enhances risk for new external genital warts in men. Int J Environ Res Public Health. 2009 Mar; 6(3): 1215-34.
49. Hansen BT, Hagerup-Jenssen M, Kjaer SK, et al. Association between smoking and genital warts: longitudinal analysis. Sex Transm Infect. 2010 Aug; 86(4): 258-62.
50. Morlat P, Roussillon C, Henard S, et al. Evolution of the causes of death among HIV patients between 2000 and 2010: results of the French National Survey "ANRS EN20 mortalite 2010. Presented at the 19th Conference on Retroviruses and Opportunistic Infections; 2012 March 5-8th; Seattle, Washington. Available at: http://www.retroconference.org/2012b/Abstracts/43761.htm.
51. Stein JH. Cardiovascular risks of antiretroviral therapy. N Engl J Med. 2007 Apr; 356(17): 1773-5.
52. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004 Apr; 109(13): 1603-8.
53. Vittecoq D, Escaut L, Chironi G, et al. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era. AIDS. 2003 Apr; 17(Suppl 1):S70-6.
54. Barbaro G, Barbarini G, Pellicelli AM. HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med. 2001 Jun; 344(23): 1799-800.
55. Centers for Disease Control and Prevention. HIV/AIDS among persons aged 50 and older. Atlanta, GA:Centers for Disease Control and Prevention, 2008 Feb. Available at: http://www.cdc.gov/hiv/topics/over50/.
56. Kuritzkes DR. HAART for HIV-1 infection: zeroing in on when to start: comment on Timing of HAART initiation and clinical outcomes in human immunodefiiency virus type 1 seroconverters. Arch Intern Med. 2011 Sep; 171(17): 1569-70.
57. Lewden C, ChÍne G, Morlat P, et al. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defi Syndr. 2007 Sep; 46(1): 72-7.
58. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004 Mar; 291(10): 1238-45.
59. Sackoff JE, Hanna DB, Pfeiffr MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006 Sep; 145(6): 397-406.
60. National Alliance of State and Territorial AIDS Directors. National ADAP monitoring project: annual report. Washington, DC: National Alliance of State and Territorial AIDS Directors, 2011 May. Available at: http://www.nastad.org/Docs/020035_2011%20 NASTAD%20National%20ADAP%20Monitoring%20Project%20Annual%20Report.pdf.
61. Kidder DP, Wolitski RJ, Campsmith ML, et al. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007 Dec; 97(12): 2238-45.
62. Blackstock OJ, Wang KH, Fiellin DA. State variation in AIDS drug assistance program prescription drug coverage for modifible cardiovascular risk factors. J Gen Intern Med. 2011 Dec;(12): 1426-33.
63. Niaura R, Shadel WG, Morrow K, et al. Human immunodefiiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000 Sep; 31(3): 808-12.
64. Land T, Warner D, Paskowsky M, et al. Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence. PLoS One. 2010 Mar; 5(3):e9770.
65. Flewelling RL, Kenney E, Elder JP, et al. First-year impact of the 1989 California cigarette tax increase on cigarette consumption. Am J Public Health. 1992 Jun; 82(6): 867-9.
66. MacKenzie TD, Bartecchi CE, Schrier RW. The human costs of tobacco use. N Engl J Med. 1994; 330(14): 975-80.
67. Houston TK, Scarinci IC, Person SD, et al. Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health. 2005 Jun; 95(6): 1056-61.